Kader Thiam
Senior Vice President & Chief Scientific Officer, Discovery, Preclinical Models & Services GenOway
Seminars
Thursday 29th January 2026
Translational Assessment of Safety Profile (Cytokine Release) of Therapeutics in Humanized Mouse Models
9:30 am
- GenO-BRGSF-HIS recapitulate key CRS features induced by biologics tested in the clinic
- Immune cells are recruited, polarized and activated into the tumor microenvironment in genO-BRGSF-HIS
- GenO-BRGSF-HIS enables assessment of both efficacy and safety in a single model
